5-HT7 receptors in the modulation of cognitive processes

[1]  K. Dave,et al.  Behavioral response to emotional stress in rabbits: role of serotonin and serotonin2A receptors , 2007, Behavioural pharmacology.

[2]  Kjell Någren,et al.  Correlation of human cold pressor pain responses with 5-HT1A receptor binding in the brain , 2007, Brain Research.

[3]  Sylvain Houle,et al.  A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[4]  Sean L Kitson,et al.  5-hydroxytryptamine (5-HT) receptor ligands. , 2007, Current pharmaceutical design.

[5]  M. Pawłowski,et al.  7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands. , 2007, Bioorganic & medicinal chemistry.

[6]  F. Tarazi,et al.  R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands. , 2007, Bioorganic & medicinal chemistry letters.

[7]  C. Lendon,et al.  Role of Serotonin Transporter Polymorphisms in the Behavioural and Psychological Symptoms in Probable Alzheimer Disease Patients , 2007, Dementia and Geriatric Cognitive Disorders.

[8]  Pradeep J Nathan,et al.  Acute Serotonin and Dopamine Depletion Improves Attentional Control: Findings from the Stroop Task , 2007, Neuropsychopharmacology.

[9]  D. Sanger,et al.  New perspectives for the treatment of disorders of sleep and arousal. , 2007, Annales pharmaceutiques francaises.

[10]  K. Lesch.  Linking emotion to the social brain , 2007, EMBO reports.

[11]  R. Djaldetti,et al.  The Effect of Duloxetine on Primary Pain Symptoms in Parkinson Disease , 2007, Clinical neuropharmacology.

[12]  E. Podrez,et al.  Contribution of EDRF and EDHF to restoration of endothelial function following dietary restrictions in hypercholesterolemic rats. , 2007, Indian journal of experimental biology.

[13]  L. Bonagamba,et al.  Involvement of central 5-HT7 receptors in modulation of cardiovascular reflexes in awake rats , 2007, Brain Research.

[14]  P. Bonaventure,et al.  Selective Blockade of 5-Hydroxytryptamine (5-HT)7 Receptors Enhances 5-HT Transmission, Antidepressant-Like Behavior, and Rapid Eye Movement Sleep Suppression Induced by Citalopram in Rodents , 2007, Journal of Pharmacology and Experimental Therapeutics.

[15]  G. Kennett,et al.  5‐HT2C receptor activation inhibits appetitive and consummatory components of feeding and increases brain c‐fos immunoreactivity in mice , 2007, The European journal of neuroscience.

[16]  L. Nandam,et al.  5‐HT7, NEUROGENESIS AND ANTIDEPRESSANTS: A PROMISING THERAPEUTIC AXIS FOR TREATING DEPRESSION , 2007, Clinical and experimental pharmacology & physiology.

[17]  Fumikazu Yokoyama,et al.  The selective serotonin reuptake inhibitor fluvoxamine suppresses post-feeding hyperactivity induced by food restriction in rats , 2007, Pharmacology Biochemistry and Behavior.

[18]  A. Meneses.  Do serotonin1–7 receptors modulate short and long-term memory? , 2007, Neurobiology of Learning and Memory.

[19]  J. Sutcliffe,et al.  The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder , 2007, Neuroscience Letters.

[20]  Joseph P. Huston,et al.  Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors , 2007, Progress in Neurobiology.

[21]  G. Csaba,et al.  Prolonged effect of stress at weaning on the brain serotonin metabolism and sexuality of female rats. , 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[22]  M. Goldman,et al.  Normal sleep and circadian rhythms: neurobiologic mechanisms underlying sleep and wakefulness. , 2006, The Psychiatric clinics of North America.

[23]  Jogeshwar Mukherjee,et al.  Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  A. Wesołowska,et al.  Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression , 2006, Neuropharmacology.

[25]  G. Debonnel,et al.  Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT , 2006, Neuroscience Letters.

[26]  D. Yan,et al.  Mapping Residues in the Ligand-Binding Domain of the 5-HT3 Receptor onto d-Tubocurarine Structure , 2006, Molecular Pharmacology.

[27]  C. González-Espinosa,et al.  An mRNA expression analysis of stimulation and blockade of 5-HT7 receptors during memory consolidation , 2006, Behavioural Brain Research.

[28]  Y. Sara,et al.  Reciprocal Interaction of Serotonin and Neuronal Activity in Regulation of cAMP-Responsive Element-Dependent Gene Expression , 2006, Journal of Pharmacology and Experimental Therapeutics.

[29]  J. Monti,et al.  Effects of the 5-HT7 receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat , 2006, Behavioural Brain Research.

[30]  J. Huston,et al.  Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine. , 2006, Trends in pharmacological sciences.

[31]  S. Rault,et al.  N-Arylsulfonyl-2-vinyltryptamines as new 5-HT6 serotonin receptor Ligands , 2006, Journal of enzyme inhibition and medicinal chemistry.

[32]  A. Shekhar,et al.  Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs , 2005, Neuroscience.

[33]  S. Henriksen,et al.  5-HT7 Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern , 2005, Biological Psychiatry.

[34]  I. Butkevich,et al.  Sequelae of Prenatal Serotonin Depletion and Stress on Pain Sensitivity in Rats , 2005, Neuroscience and Behavioral Physiology.

[35]  A. Meneses,et al.  Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task , 2005, Behavioural Brain Research.

[36]  R Todd Constable,et al.  Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Haller,et al.  The activation of raphe serotonergic neurons in normal and hypoarousal-driven aggression: A double labeling study in rats , 2005, Behavioural Brain Research.

[38]  M. Esiri,et al.  Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer’s disease , 2005, Psychopharmacology.

[39]  A. Meneses,et al.  5-HT1A receptor expression during memory formation , 2005, Psychopharmacology.

[40]  P. Whiting,et al.  Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression , 2005, Neuropharmacology.

[41]  A. Meneses.  Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task , 2004, Behavioural Brain Research.

[42]  Katarina Varnäs,et al.  Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [ 3 H ]SB-269970 , 2004, Neuroscience Letters.

[43]  J. Sutcliffe,et al.  Functional, molecular and pharmacological advances in 5-HT7 receptor research. , 2004, Trends in pharmacological sciences.

[44]  A. Meneses,et al.  Expression of the 5-HT receptors in rat brain during memory consolidation , 2004, Behavioural Brain Research.

[45]  Tao Xin,et al.  Recent progress in 5-HT7 receptors: potential treatment of central and peripheral nervous system diseases , 2004 .

[46]  Bryan L. Roth,et al.  Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders , 2004, Psychopharmacology.

[47]  J. Sutcliffe,et al.  Mice lacking 5‐HT7 receptors show specific impairments in contextual learning , 2004, The European journal of neuroscience.

[48]  E. Lacivita,et al.  Studies on 1‐arylpiperazine derivatives with affinity for rat 5‐HT7 and 5‐HT1A receptors , 2004, The Journal of pharmacy and pharmacology.

[49]  J. Leysen,et al.  5-HT2 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[50]  C. Marsden,et al.  5-ht6 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[51]  L. Lanfumey,et al.  5-HT1 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[52]  B. Costall,et al.  5-HT3 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[53]  J. Hagan,et al.  5-HT7 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[54]  J. Bockaert,et al.  5-HT4 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[55]  A. Meneses,et al.  8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production , 2004, Behavioural Brain Research.

[56]  R. Prado-Alcalá,et al.  Blockade of striatal 5-HT2 receptors produces retrograde amnesia in rats. , 2003, Life sciences.

[57]  A. Meneses.  A pharmacological analysis of an associative learning task: 5-HT(1) to 5-HT(7) receptor subtypes function on a pavlovian/instrumental autoshaped memory. , 2003, Learning & memory.

[58]  G. Mcallister,et al.  The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor , 2003, Neuropharmacology.

[59]  J. Hagan,et al.  SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats , 2003, British journal of pharmacology.

[60]  A. Pack,et al.  Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning. , 2003, Learning & memory.

[61]  J. Sutcliffe,et al.  No hypothermic response to serotonin in 5-HT7 receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Meneses,et al.  Involvement of 5-HT2A/2B/2C Receptors on Memory Formation: Simple Agonism, Antagonism, or Inverse Agonism? , 2002, Cellular and Molecular Neurobiology.

[63]  J. Huston,et al.  Anxiolytic-like effects of substance P fragment (SP1–7) in non-human primates (Callithrix penicillata) , 2002, Peptides.

[64]  T. Blackburn,et al.  The medical benefit of 5-HT research , 2002, Pharmacology Biochemistry and Behavior.

[65]  R. Prosser,et al.  Translational and Transcriptional Inhibitors Block Serotonergic Phase Advances of the Suprachiasmatic Nucleus Circadian Pacemaker In Vitro , 2002, Journal of biological rhythms.

[66]  Daniel Hoyer,et al.  Molecular, pharmacological and functional diversity of 5-HT receptors , 2002, Pharmacology Biochemistry and Behavior.

[67]  C. Tomaz,et al.  Non-human primate models for investigating fear and anxiety , 2002, Neuroscience & Biobehavioral Reviews.

[68]  E. Kandel.  The Molecular Biology of Memory Storage: A Dialogue Between Genes and Synapses , 2001, Science.

[69]  J. Raymond,et al.  Multiplicity of mechanisms of serotonin receptor signal transduction. , 2001, Pharmacology & therapeutics.

[70]  J. Seckl,et al.  Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus , 2001, Neuroscience Letters.

[71]  E. Brown,et al.  The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians. , 2001, Primary care companion to the Journal of clinical psychiatry.

[72]  G. Kennett,et al.  Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors , 2001, Neuropharmacology.

[73]  A. Deutch,et al.  Distribution of serotonin 5‐HT2A receptors in afferents of the rat striatum , 2001, Synapse.

[74]  A. Meneses.  Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation , 2001, Behavioural Brain Research.

[75]  M Toth,et al.  Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[76]  G. Perrault,et al.  The effects of compounds varying in selectivity as 5-HT1A receptor antagonists in three rat models of anxiety , 2000, Neuropharmacology.

[77]  J. Hagan,et al.  Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist , 2000, British journal of pharmacology.

[78]  J. D. McGaugh,et al.  The contribution of pharmacology to research on the mechanisms of memory formation. , 2000, Trends in pharmacological sciences.

[79]  M. Pangalos,et al.  The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models , 2000, Journal of Neuroscience Methods.

[80]  J. Leysen,et al.  5-HT7 receptors: current knowledge and future prospects. , 2000, Trends in pharmacological sciences.

[81]  J. D. McGaugh.  Memory--a century of consolidation. , 2000, Science.

[82]  M. Buhot,et al.  Role of serotonin in memory impairment , 2000, Annals of medicine.

[83]  A. Meneses,et al.  5-HT system and cognition , 1999, Neuroscience & Biobehavioral Reviews.

[84]  P B Hedlund,et al.  Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors. , 1999, Biochemical pharmacology.

[85]  A. Eison,et al.  Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus , 1999, Neuropsychopharmacology.

[86]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[87]  P. Wong,et al.  Regulation of striatal dopamine release through 5‐HT1 and 5‐HT2 receptors , 1999, Journal of neuroscience research.

[88]  P. Szot,et al.  Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing , 1998, Neuropharmacology.

[89]  J. Lieberman,et al.  Serotonergic basis of antipsychotic drug effects in schizophrenia , 1998, Biological Psychiatry.

[90]  N. Barnes,et al.  Selective labelling of 5-HT7 receptor recognition sites in rat brain using [3H]5-carboxamidotryptamine , 1998, Neuropharmacology.

[91]  T. Branchek,et al.  Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation. , 1998, The Journal of pharmacology and experimental therapeutics.

[92]  C. Marsden,et al.  Antisense Oligonucleotide‐Induced Reduction in 5‐Hydroxytryptamine7 Receptors in the Rat Hypothalamus Without Alteration in Exploratory Behaviour or Neuroendocrine Function , 1998, Journal of neurochemistry.

[93]  D. Storm,et al.  Stimulation of Type 1 and Type 8 Ca2+/Calmodulin-sensitive Adenylyl Cyclases by the Gs-coupled 5-Hydroxytryptamine Subtype 5-HT7AReceptor* , 1998, The Journal of Biological Chemistry.

[94]  J. Hagan,et al.  Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719 , 1998, British journal of pharmacology.

[95]  P. Pauwels.  5-HT 1B/D receptor antagonists. , 1997, General pharmacology.

[96]  R. Eglen,et al.  Cloning, expression and pharmacology of a truncated splice variant of the human 5‐HT7 receptor (h5‐HT7(b)) , 1997 .

[97]  M. Ramírez,et al.  5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices , 1997, Brain Research.

[98]  C. Vargas,et al.  Expression of 5-HT7 receptor mRNA in rat brain during postnatal development , 1997, Neuroscience Letters.

[99]  R. Kohen,et al.  Four 5‐Hydroxytryptamine7 (5‐HT7) Receptor Isoforms in Human and Rat Produced by Alternative Splicing: Species Differences Due to Altered Intron‐Exon Organization , 1997, Journal of Neurochemistry.

[100]  D. Bakish,et al.  Serotonin in the Central Nervous System and Periphery. , 1997 .

[101]  H. Ladinsky,et al.  Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT 1B receptors. , 1996, The Journal of pharmacology and experimental therapeutics.

[102]  N. Barnes,et al.  5‐HT4 receptor‐mediated modulation of 5‐HT release in the rat hippocampus in vivo , 1996, British journal of pharmacology.

[103]  T. Branchek,et al.  A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5‐ht7 receptor in rat brain , 1996, British journal of pharmacology.

[104]  J. Harvey.  Serotonergic regulation of associative learning , 1995, Behavioural Brain Research.

[105]  E. Wong,et al.  Central 5-HT4 receptors. , 1995, Trends in pharmacological sciences.

[106]  S. K. Patra,et al.  Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat. , 1995, European journal of pharmacology.

[107]  H. Lübbert,et al.  Expression of serotonin receptor mRNAs in blood vessels , 1995, FEBS letters.

[108]  R. Eglen,et al.  Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. , 1995, European journal of pharmacology.

[109]  C. Marsden,et al.  Attenuation of CCK-induced aversion in rats on the elevated x-Maze by the selective 5-HT1A receptor antagonists (+)WAY100135 and WAY100635 , 1995, Neuropharmacology.

[110]  J. Slangen,et al.  Serotonergic drug effects on a delayed conditional discrimination task in the rat; involvement of the 5-HT1A receptor in working memory , 1995, Journal of psychopharmacology.

[111]  R. Eglen,et al.  Characterization and distribution of putative 5‐ht7 receptors in guinea‐pig brain , 1995, British journal of pharmacology.

[112]  H. Saito,et al.  Inhibition by 5‐HT7 receptor stimulation of GABAA receptor‐activated current in cultured rat suprachiasmatic neurones. , 1994, The Journal of physiology.

[113]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[114]  G. Martin,et al.  Receptors for 5-Hydroxytryptamine: Current perspectives on classification and nomenclature , 1994, Neuropharmacology.

[115]  D. Sibley,et al.  Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[116]  T. Branchek,et al.  Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. , 1993, The Journal of biological chemistry.

[117]  J. Schwartz,et al.  Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[118]  M. Erlander,et al.  A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms , 1993, Neuron.

[119]  D. Sibley,et al.  Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. , 1993, The Journal of biological chemistry.

[120]  Y. Cui,et al.  Thermoregulatory responses following injection of 5-hydroxytryptamine into the septohippocampal complex in rats , 1993, Pharmacology Biochemistry and Behavior.

[121]  I. Izquierdo,et al.  Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat. , 1992, Behavioral and neural biology.

[122]  I. Lucki,et al.  5-Hydroxytryptamine1A receptors and behavioral responses. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[123]  C. Compoint,et al.  Serotonergic projections from the nodose ganglia to the nucleus tractus solitarius: an immunohistochemical and double labeling study in the rat , 1990, Neuroscience Letters.

[124]  B. Costall,et al.  The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates , 1990, Pharmacology Biochemistry and Behavior.

[125]  Mizuta Eiji,et al.  Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys , 1990 .

[126]  O. Bosler,et al.  Central serotonergic projections to the nucleus tractus solitarii: Evidence from a double labeling study in the rat , 1988, Neuroscience.

[127]  W. Feniuk,et al.  5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava. , 1986, Life sciences.

[128]  C. Dourish,et al.  Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) , 1985, Brain Research Bulletin.

[129]  J. Fozard,et al.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. , 1984, European journal of pharmacology.

[130]  P P Humphrey,et al.  5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. , 1983, European journal of pharmacology.

[131]  S. Hjorth,et al.  8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity , 1982, Journal of Neural Transmission.

[132]  H. Steinbusch,et al.  Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals , 1981, Neuroscience.

[133]  B. Jacobs,et al.  Brain stem and spinal cord mediation of a serotonergic behavioral syndrome , 1975, Brain Research.

[134]  D. Grahame-Smith.  STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN , 1971, Journal of neurochemistry.

[135]  P. Reebye,et al.  Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. , 2007, Archives of pediatrics & adolescent medicine.

[136]  I. Izquierdo,et al.  Pharmacological Findings on the Biochemical Bases of Memory Processes: A General View , 2004, Neural plasticity.

[137]  C. Dourish,et al.  Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat , 2004, Psychopharmacology.

[138]  E. sanders-Bush,et al.  Serotonin and brain development. , 2004, International review of neurobiology.

[139]  Joseph E LeDoux,et al.  Structural plasticity and memory , 2004, Nature Reviews Neuroscience.

[140]  D. Hoyer,et al.  Serotonin receptors and systems: endless diversity? , 2002 .

[141]  L. Schechter,et al.  The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease. , 2002, Current pharmaceutical design.

[142]  Dennis S. Charney,et al.  Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .

[143]  J. Halford,et al.  Pharmacology of appetite suppression. , 2000, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[144]  A. Sleight,et al.  Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. , 1995, Molecular pharmacology.

[145]  Y. Sugimoto,et al.  The involvement of serotonergic and dopaminergic systems in hypothermia induced in mice by intracerebroventricular injection of serotonin. , 1988, Japanese journal of pharmacology.

[146]  S. Feldman.  Neural pathways mediating adrenocortical responses. , 1985, Federation proceedings.

[147]  I. Lucki,et al.  Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.